Australia markets closed

PYC Therapeutics Limited (PYC.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.06400.0000 (0.00%)
At close: 10:49AM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 232.21M
Enterprise value 189.24M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)4.96
Enterprise value/revenue N/A
Enterprise value/EBITDA -11.48

Trading information

Stock price history

Beta (5Y monthly) 0.39
52-week change 3-57.33%
S&P500 52-week change 3-11.93%
52-week high 30.1600
52-week low 30.0610
50-day moving average 30.0776
200-day moving average 30.1135

Share statistics

Avg vol (3-month) 3652.51k
Avg vol (10-day) 3744.75k
Shares outstanding 53.18B
Implied shares outstanding 6N/A
Float 81.09B
% held by insiders 161.33%
% held by institutions 10.01%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2021
Most-recent quarter (mrq)31 Dec 2021


Profit margin -185.43%
Operating margin (ttm)-192.12%

Management effectiveness

Return on assets (ttm)-18.92%
Return on equity (ttm)-31.85%

Income statement

Revenue (ttm)9.07M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)3,840.90%
Gross profit (ttm)3.07M
EBITDA -16.86M
Net income avi to common (ttm)-16.82M
Diluted EPS (ttm)-0.0050
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)43.64M
Total cash per share (mrq)0.01
Total debt (mrq)673.6k
Total debt/equity (mrq)1.41
Current ratio (mrq)12.31
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-12.95M
Levered free cash flow (ttm)-7.16M